Renin angiotensin system-regulating aminopeptidase activities in serum of pre- and postmenopausal women with breast cancer

Breast

Volumn 20, Issue 5, 2011, Pages 444-447

  Martínez Martos, José Manuel ^a   Carrera González, María del Pilar ^a   Dueñas, Basilio ^a   Mayas, María Dolores ^a   García, María Jesús ^a   Ramírez Expósito, María Jesús ^a  

^a UNIVERSITY OF JAÉN   (Spain)

Author keywords

Aminopeptidases; Breast cancer; Menopause; Renin angiotensin system

Indexed keywords

AMINOPEPTIDASE; AMINOPEPTIDASE B; ANGIOTENSIN II; ANGIOTENSIN II [3-8]; ANGIOTENSIN III; ASPARTYL AMINOPEPTIDASE; MICROSOMAL AMINOPEPTIDASE;

ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DISEASE MARKER; ENZYME BLOOD LEVEL; ENZYME REGULATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULARIZATION;

EID: 80052503810     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2011.04.008     Document Type: Article

References (38)

1. Juillerat-Jeanneret L., ohm S., Hamou M.F., Pinet F. Regulation of aminopeptidase A in human brain tumor vasculature: evidence for a role of transforming growth factor beta. Lab Invest 2000, 80:973-980.
2. Fernández L.A., Twickler J., Mead A. Neovascularization produced by angiotensin II. J Lab Clin Med 1985, 105:141-145.
3. Le Noble F.A., Hekking J.W., van Straaten H.W., Slaaf D.W., Struyker Boudier H.A. Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo. Eur J Pharmacol 1991, 195:305-306.
4. Hu D.E., Hiley C.R., Fan T.P. Comparative studies of the angiogenic activity of vasoactive intestinal peptide, endothelins-1 and - 3 and angiotensin II in rat sponge mode. Br J Pharmacol 1996, 117:541-545.
5. Andrade S.P., Cardoso C.C., Machado R.D.P., Beraldo W.T. Angiotensin II-induced angiogenesis in sponge implant in mice. Int J Microcirc Clin Exp 1996, 16:302-307.
6. Walsh D.A., De He, Wharton J., Catravas J.D., Blake D.R., Fan T.P.D. Sequential development of angiotensin receptors and angiotensin I converting enzyme during angiogenesis in the rat subcutaneous sponge granuloma. Br J Pharmacol 1997, 120:1302-1311.
7. Ardaillou R., Chansel D. Synthesis and effects of active fragments of angiotensin II. Kidney Int 1997, 52:1458-1468.
8. Berstein L. Epidemiology of endocrine-related risk factors for breast cancer. J Mammary Gland Biol Neoplasia 2002, 7:3-15.
9. Russo J., Russo R.H. The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol 2006, 102:89-96.
10. Martínez J.M., Prieto I., Ramirez M., De Gasparo M., Hermoso F., Arias J.M., et al. Sex differences and age related changes in human serum aminopeptidase A activity. Clin Chim Acta 1998, 274:53-61.
11. Martínez M., Ramírez M.J., Prieto I., Alba F., Ramírez M. Sex differences and in vitro effects of steroid on serum aminopeptidase activity. Peptides 1998, 19:1637-1640.
12. Kang A.K., Duncan J.A., Cattran D.C., Floras J.S., Lai V., Scholey J.W., et al. Effects of oral contraceptives on the rennin angiotensin system and renal function. Am J Physiol Regul Integr Comp Physiol 2001, 280:R807-R813.
13. Umeda M., Ichikawa S., Kanda T., Sumino H., Kobayashi I. Hormone replacement therapy increases plasma level of angiotensin II in postmenopausal hypertensive women. Am J Hypertens 2001, 14:206-211.
14. Seely E.W., Brosnihan K.B., Jeunemaitre X., Okamura K., Williams G.H., Hollenberg N.K., et al. Effects of conjugated oestrogen and droloxifene on the rennin-angiotensin system, blood pressure and renal blood flow in postmenopausal women. Clin Endocrinol (Oxf) 2004, 60:315-321.
15. Harvey P.J., Wing L.M., Savage J., Molloy D. the effects of different types and doses of oestrogen replacement therapy on clinical and ambulatory blood pressure and the rennin angiotensin system in normotensive postmenopausal women. J Hypertens 1999, 17:405-411.
16. Zacharieva S., Kirilov G., Kalinov K., Shigarminova R., Nachev E., Orbetzova M., et al. Effects of different hormone replacement therapy regimens on circadian blood pressure profile and active rennin in postmenopausal women. Gynecol Endocrinol 2002, 16:461-467.
17. Karjalainen A.H., Ruskoaho H., Vuolteenaho O., Heikkinen J.E., Backstrom A.C., Savolainen M.J., et al. Effects of estrogen replacement therapy on natriuretic peptides and blood pressure. Maturitas 2004, 47:201-208.
18. Proudler A.J., Cooper A., whitehead M., Stevenson J.C. Effects of oestrogen-only and oestrogen-progestogen replacement therapy upon circulating angiotensin I converting enzyme activity in postmenopausal women. Clin Endocrinol (Oxf) 2003, 58:30-35.
19. Oelkers W.K. Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Steroids 1996, 61:166-171.
20. Nickenig G., Baumer A.T., Grohe C., Kahlert S., Strehlow K., Rosenkranz S., et al. Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation 1998, 97:2197-2201.
21. Sapoznik S., Cohe B., Tzuman Y., Meir G., Ben-Dor S., Harmelin A., et al. Gonadotropin regulated lymphangiogenesis in ovarian cancer is mediated by LEDGF induced expression of VEGF-C. Cancer Res 2009, 69:9306-9314.
22. Carrera M.P., Ramírez-Expósito M.J., Valenzuela M.T., García Mj, Mayas M.D., Martinez-Martos J.M. Glutamyl- but not aspartyl-aminopeptidase activity is modified in serum of N-methyl nitrosourea-induced rat mammary tumours. Anticancer Res 2004, 24:801-805.
23. Carrera M.P., Ramírez Expósito M.J., Valenzuela Mt, Dueñas B., García M.J., Mayas M.D., et al. Renin-angiotensin system regulating aminopeptidase activities are modified in the pineal gland of rats with breast cancer induced by N-methyl-nitrosourea. Cancer Invest 2006, 24:149-153.
24. García M.J., Martínez-Martos J.M., Mayas M.D., Carrera M.P., Ramirez -Expósito M.J. Hormonal status modifies renin-angiotensin system-regulating aminopeptidases and vasopressin-degrading activity in the hypothalamus-pituitary-adrenal axis of male mice. Life Sci 2003, 73:525-538.
25. Dzau V.J. Envolving concepts of the rennin-angiotensin system. Focus on renal and vascular mechanism. Am J Hypertens 1988, 1:334S-337S.
26. Kinoshita J., Fushida S., Harada S., Yagi Y., Fujita H., Kinami S., et al. Local angiotensin II-generation in human gastric cáncer: corretlation with tumor progression through the activation of ERK1/2, NF-kappaB and survivin. Int J Oncol 2009, 34:1573-1582.
27. + ATPase activity and cell growth by calcium-independent pathway in MCF-7 breast cancr cells. J Endocrinol 2002, 173:315-323.
28. Suganuma T., Ino K., Shibata K., Kajiyama H., Nagasaka T., Mizutani S., et al. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion angiogenesis and peritoneal dissemination. Clin Cancer Res 2005, 11:2686-2694.
29. Amaya K., Ohta T., Kitagawa M., Takamura H., Fujimura T., Nishimura G., et al. Angiotensin II activates MAP Kinase and NF-Kappa B through angiotensin II type I receptor in human pancreatic cancer cells. Int J Oncol 2004, 25:849-856.
30. Zhao Y., Chen X., Cail L., Yang Y., Sui G., Fu S. Angiotensin II/ Angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survical via PI3 kinase/Akt pathway. J Cell Physiol 2010, 225:168-173.
31. Herr F., Baal N., Reisinger K., Lorenz A., McKinnon T., Presissner K.T., et al. HCG in the regulation of placental angiogenesis. Results of an in vitro study. Placenta 2007, 28:S85-S93.
32. Efrati S., Berman S., Goldfinger N., Erez N., Averbukh Z., Golik A., et al. Enhanced angiotensin II production by renal mesangium is responsible for apoptosis/proliferation of endothelial and epithelial cells in a model of malignant hypertension. J Hypertens 2007, 25:1041-1052.
33. Garcia M.J., Martinez-Martos J.M., Mayas M.D., Carrera M.P., De la Chica S., Cortes P., et al. Hormonal status modified rennin-angiotensin system-regulating aminopeptidases and vasopressin-degrading activity in the hypothalamus-pituitary-adrenal axis of female mice. Med Chem 2008, 4:336-347.
34. Ely D.L., Paradise N.F., Folkow B. Blood pressure and neurogenic adaptations to reduced dietary sodium in the SHR model of hypertension. Klin Wochenschr 1991, 69:58-72.
35. Reckelhoff J.F., Zhang H., Granger J.P. Decline in renal hemodynamic function in aging SHR: role of androgens. Hypertension 1997, 30:677-681.
36. Dekx F.H., Steunkel C., Schalekamp M.P., Visser W., Huisveld I.H., Schalekamp M.A. Inmunoreactive rennin, prorenin and enzymatically active rennin in plasma during pregnancy and in women taking oral contraceptives. J Clin Endocrinol Metab 1986, 63:1008-1015.
37. Schunkert H., Danser A.H., Hense H.W., Derkx F.H., Kurzinger S., Riegger G.A. Effects of estrogen replacement therapy on the rennin-angiotensin system in postmenopausal women. Circulation 1997, 95:39-45.
38. Chappell M.C., Gallagher P.E., Averill D.B., Ferrario C.M., Brosnihan K.B. Estrogen or the AT1 antagonist olmesartan reverses the development of profound hypertension in congenic mRen2 Lewis rat. Hypertension 2003, 42:781-786.